We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TCBK:NASDAQTriCo Bancshares Analysis

Data as of 2026-09-01 - not real-time

$53.38

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

TriCo Bancshares trades at $53.38, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have lost 10.7%. With RSI at 31.0 the momentum picture is approaching oversold, alongside a bearish MACD signal. Price has been bracketed by support at $53.23 and resistance at $59.01.
Multiples put this in undervalued territory: 12.8 times earnings against the sector's 16.9. Consensus targets land 17.7% above where the shares trade now. Revenue is growing at 10.4% on a 31.8% profit margin. The 2.70% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 12.8%, a beta of 0.49 and a maximum drawdown of 13.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.

Top Market Events

CHICO, Calif., August 21, 2026--The Board of Directors of TriCo Bancshares NASDAQ: TCBK the "Company" , parent company...TriCo TCBK shares rallied 12% in the last trading session to close at $60.The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 50.97
  • MACD momentum is negative
  • 30-day price change of -10.7%

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 12.8 versus sector average of 16.9
  • Trading above the 200-day average of 50.97
  • Analyst targets imply +17.7% versus the current price

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.8 versus sector average of 16.9
  • Analyst targets imply +17.7% versus the current price
  • Profit margin of 31.8% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth10.40%
Profit Margin31.79%
P/E Ratio12.8
ROE10.38%
ROA1.36%
P/B Ratio1.3
Op. Cash Flow$138.4M
Industry P/E16.9

Technical Analysis

TrendNeutral
RSI31.0
Support$53.23
Resistance$59.01
MA 20$56.14
MA 50$56.31
MA 200$50.97
MACDBearish
VolumeStable
Fear & Greed Index93.18

Valuation

Fair Value$59.72
Target Price$62.81
Upside/Downside17.66%
GradeUndervalued
TypeValue
Dividend Yield2.70%

Risk Assessment

Beta0.49
Volatility12.81%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.